Chapter 28. Parvovirus B191

  1. Errol R. Norwitz MD, PhD Professor Director1,
  2. Michael A. Belfort MD, PhD Professor Director2,3,
  3. George R. Saade MD Professor4 and
  4. Hugh Miller MD5

Published Online: 6 MAY 2010

DOI: 10.1002/9781444314489.ch28

Obstetric Clinical Algorithms: Management and Evidence

Obstetric Clinical Algorithms: Management and Evidence

How to Cite

Norwitz, E. R., Belfort, M. A., Saade, G. R. and Miller, H. (2010) Parvovirus B191, in Obstetric Clinical Algorithms: Management and Evidence, Wiley-Blackwell, Oxford, UK. doi: 10.1002/9781444314489.ch28

Author Information

  1. 1

    Department of Obstetrics, Gynecology & Reproductive Sciences, Yale-New Haven Hospital, New Haven, CT, USA

  2. 2

    Department of Obstetrics and Gynecology, University of Utah School of Medicine, Salt Lake City, UT, USA

  3. 3

    Perinatal Research and Fetal Therapy Program, HCA Healthcare, Nashville, TN, USA

  4. 4

    Department of Obstetrics and Gynecology, University of Texas Medical Branch, Galveston, TX, USA

  5. 5

    Department of Obstetrics and Gynecology, University of Arizona, Tucson, AZ, USA

Publication History

  1. Published Online: 6 MAY 2010
  2. Published Print: 23 APR 2010

ISBN Information

Print ISBN: 9781405181112

Online ISBN: 9781444314489

SEARCH

Keywords:

  • parvovirus B19 - single-stranded DNA virus causing fifth disease (erythema infectiosum);
  • fifth disease transmission - hand-to-mouth contact and respiratory secretions;
  • risk factors - frequent contact with children aged 5–18 years;
  • fifth disease symptoms - reticular facial and truncal rash, upper respiratory tract symptoms;
  • maternal parvovirus B19 infection - confirmed by serologic testing;
  • fetal infection confirmation - detection of viral particles/DNA in fetal serum